Navigation Links
Visage Imaging Receives FDA 510(k) Clearance for its Latest Thin Client Product Release
Date:12/15/2008

CARLSBAD, Calif., Dec. 15 /PRNewswire-FirstCall/ -- Visage Imaging(R), Inc., a wholly owned subsidiary of Mercury Computer Systems, Inc. (NASDAQ: MRCY), announced that it has received FDA 510(k) clearance to market its latest thin client product release, Visage CS 3.1. This release brings significant enhancements to its prior offerings in cardiac and other tools, and includes new optional Neuroradiology and Oncology applications. The Neuro option facilitates brain perfusion analysis in CT and MRI imaging, while the Oncology option provides tools for analyzing, documenting, and comparing lesions for multiple modalities, including Standardized Update Value (SUV)- based analysis for PET-CT.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081013/NEM013LOGO )

"Visage Imaging's thin client solution instantly brings workstation-class diagnostic tools to the numerous workplaces of those who need them," said Hartmut Schirmacher, Director of Product Management for Visage Imaging. "Compared to typical workstations or other web-based 'fat' solutions, Visage CS offers far superior performance across the board, especially when viewing and processing large data volumes. Furthermore, Visage CS 3.1 will affordably allow for broader access to state-of-the-art applications throughout the enterprise."

In addition to the new application options, Visage CS 3.1 features numerous new and streamlined measurement and post processing tools such as advanced 3D segmentation, ROI-based analysis and time-value curves, and improved editing of cardiac LV models.

For more information on Visage CS 3.1, visit www.visageimaging.com, or contact Visage Imaging at info@visageimaging.com or +1 888-3D-VISAGE.

Visage Imaging, Inc. - Visioneering Science for Life(R)

Visage Imaging, Inc. (www.visageimaging.com) designs and engineers clinical products that present its customers with the ability to overcome demanding market challenges and improve diagnostic results with accuracy and expedience. As a wholly owned subsidiary of Mercury Computer Systems, Inc., Visage Imaging incorporates Mercury's 20+ years of technical expertise and deep knowledge of the science behind diagnostic applications into its practice, and leverages this experience to push the boundaries of what is possible within its domain.

Through collaborative learning, Visage Imaging has built a nimble, creative organization: one that is first to market with innovative 3D clinical applications, offers best-in-class 3D products that are unique and reliable, and helps its customers to accelerate their own market innovation and clinical benefit.

Forward-Looking Safe Harbor Statement

This press release contains certain forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995, including those relating to the FDA 510(k) clearance for Visage Imaging to market its latest thin client product release, Visage CS 3.1. You can identify these statements by our use of the words "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. Such risks and uncertainties include, but are not limited to, general economic and business conditions, including unforeseen weakness in Visage Imaging's markets, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, continued funding of defense programs, the timing of such funding, changes in the U.S. Government's interpretation of federal procurement rules and regulations, market acceptance of Visage Imaging's products, shortages in components, production delays due to performance quality issues with outsourced components, inability to fully realize the expected benefits from acquisitions or delays in realizing such benefits, challenges in integrating acquired businesses and achieving anticipated synergies, and difficulties in retaining key customers. These risks and uncertainties also include such additional risk factors as are discussed in Mercury Computer Systems, Inc.'s recent filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended June 30, 2008. Visage Imaging cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Visage Imaging undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made.

    Contacts:
    Diane M. Clifford, Director of Global Marketing
    Visage Imaging, Inc.
    Phone: 978-967-1168
    E-mail: dclifford@visageimaging.com

    Kathleen Sniezek, Corporate Public Relations Manager
    Mercury Computer Systems, Inc.
    Phone: 978-967-1126
    E-mail: ksniezek@mc.com

Visage, Visage Imaging, and Visioneering Science for Life are registered trademarks of Mercury Computer Systems, Inc. Other product and company names mentioned may be trademarks and/or registered trademarks of their respective holders.


'/>"/>
SOURCE Mercury Computer Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Visage Imaging and Agfa Healthcare Sign Worldwide Agreement to Integrate Visage Offerings to the IMPAX(TM) Suites
2. Visage Imaging Expands Availability of Its Advanced Visualization Offering
3. Thinnovation at RSNA 2007: Visage Imaging to Showcase Award-Winning Thin Client PACS Solutions
4. Visage Imaging to Provide Fully Integrated Thin Client-Based Solution to Tufts Medical Center
5. Visage Imaging to Provide Enterprise-Wide Thin Client Solutions to Beebe Medical Center
6. Visage Imaging and Viatronix Sign Comprehensive Marketing Agreement for Virtual Colonoscopy Product
7. Brain imaging reveals breakdown of normal emotional processing
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. Fry Construction Selected for High-Profile Medical Imaging Project
10. Elbit Medical Imaging Ltd. Announces Publication of a Prospectus in Israel
11. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology: